Cuprina Holdings Ltd (CUPR) - Market Cap to Earnings

Corporate emblem and logo of Cuprina Holdings Limited (CUPR)

The market capitalization trend for Cuprina Holdings (Cayman) Ltd (CUPR) demonstrates a value of -3.60, characterizing the company as a specialist in complex wound therapy. The business is protected by exclusive patents and stringent government oversight in Singapore. Its environmental strategy is based on the use of biodegradable materials and the recycling of bio-waste. Operational efficiency is ensured by a proprietary express delivery system that maintains strict temperature control for biomedical preparations.

Cuprina Holdings Limited - CUPR Price to Earnings Ratio (period 05/17/2025 - 11/18/2026)

Analytical breakdowns for Cuprina Holdings Limited (CUPR)

- stock value and consensus price forecast:
Comprehensive company analysis:Cuprina Holdings (Cayman) Ltd. (CUPR)
Signature product of Cuprina Holdings Ltd

The Singaporean laboratory complex of Cuprina Holdings (Cayman) Ltd (CUPR) requires high expenditures to maintain sterility and energy autonomy, which directly impacts the bottom line. By analyzing the company's historical P/E, an investor assesses the ratio of market capitalization to net income to determine whether the business valuation is justified by current margins and the ability to generate a return on invested capital amid cost-push inflation.

Analysis of competing companies

Market Cap to Earnings hcahealthcare.com HCA|Price to Earnings Ratio Tenet Healthcare (THC)|Fresenius Medical Care - Price to Earnings Multiple|Price to Earnings Ratio Solventum SOLV|Market Price to Net Income Ratio EHC (Encompass Health)|UHS: Price to Earnings Ratio|DVA (DaVita) - Price to Earnings Multiple|RadNet Corp (RDNT) - Price to Earnings Ratio|Market Cap to Earnings Option Care Corp (OPCH)|Price to Earnings Ratio SGRY|PINC: Company Value to Net Income|P/E Multiple EYE|PGNY - Market Cap to Earnings|P/E Multiple ARDT (ardenthealth.com)|SEM - Price to Earnings Ratio|Astrana Corp - P/E Multiple|Company Value to Net Income MD (mednax.com)|U.S. Physical Therapy, Inc. (USPH) - Price to Earnings Ratio|Market Cap to Earnings Pennant Group (PNTG)|ORGO (Organogenesis Holdings Inc.) - P/E Multiple|NUTX: Company Value to Net Income|P/E Multiple AUNA|Price to Earnings Ratio SBC Medical Group Holdings Inc SBC|Price to Earnings Ratio Jeuveau EOLS|Company Value to Net Income CYH|SKIN: Price to Earnings Ratio|Company Value to Net Income MDWD (MediWound)|BTMD (biote.com) - Price to Earnings Ratio|Price to Earnings Ratio thejoint.com|DCGO (DocGo, Inc.) - P/E Multiple|Price to Earnings Ratio PIII|Price to Earnings Ratio GANX (Gain Therapeutics Inc.)|P/E Multiple EUDA Health (EUDA)|Basel Medical Group - Price to Earnings Ratio|Market Price to Net Income Ratio CLGN (CollPlant Ltd)|CCM: Price to Earnings Ratio|Company Value to Net Income AMS (American Shared Hospital Services)|MRM: P/E Multiple|Market Cap to Earnings Avalon GloboCare Corp (ALBT)|Price to Earnings Ratio DIH Holding|XAGE: Company Value to Net Income|P/E Multiple NIVF|P/E Multiple ATI Physical Therapy Inc. (ATIP)|P/E Multiple CMAX (caremax.com)|Market Price to Net Income Ratio KDLY (Kindly Health)|MODV - Price to Earnings Ratio|Market Cap to Earnings novointegrated.com|SunLink Health Systems (SSY) - Price to Earnings Ratio|Price to Earnings Ratio IMAC Holdings Inc